TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24742226

Group type: EXPERIMENTAL
Intervention: Yuzu scent inhalation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unscented water (control)
Number of subjects: 20
Study: 22985564

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) treatment
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Nucleoside analogue (NA) treatment
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: HBeAg-negative group
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: HBeAg-positive group
Number of subjects: 198
Study: 20504358

Group type: EXPERIMENTAL
Intervention: Multi-dimensional and multi-professional educational senior meetings
Number of subjects: 450

Group type: COMPARATOR
Intervention: Preventive home visits
Number of subjects: 450
Study: 18672991

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG) - no intervention
Number of subjects: 30
Study: 16393755

Group type: EXPERIMENTAL
Intervention: Parallel search
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Serial search
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low performing patients
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: LH MCA strokes
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Impaired rightward shifting
Number of subjects: 31
Study: 12891074

Group type: EXPERIMENTAL
Intervention: Triple nucleoside regimen (Trizivir)
Number of subjects: 40

Group type: COMPARATOR
Intervention: NNRTI-containing regimen (baseline therapy)
Number of subjects: 40
Study: 10501818

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg per day
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg per day
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg per day
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg per day
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: All statins
Number of subjects: 197
Study: 9375153

Group type: EXPERIMENTAL
Intervention: Late posttraumatic seizures (occurring 8 or more days posttrauma)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Head injured patients with late posttraumatic seizures
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Head injured patients with late posttraumatic seizures (after controlling for head injury severity)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Patients who remained seizure free
Number of subjects: 210
Study: 2006656

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 742

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 742
Study: 6802411

Group type: EXPERIMENTAL
Intervention: Auscultatory percussion
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Phonoscopy
Number of subjects: 89
Study: 31910385

Group type: EXPERIMENTAL
Intervention: Non-RCTs
Number of subjects: 21

Group type: COMPARATOR
Intervention: RCTs
Number of subjects: 21
Study: 31362776

Group type: EXPERIMENTAL
Intervention: Extracorporeal carbon dioxide removal (ECCO2R) added to non-invasive ventilation (NIV)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-invasive ventilation (NIV) alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ECCO2R and/or NIV
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ECCO2R and NIV
Number of subjects: 24
Study: 30092844

Group type: EXPERIMENTAL
Intervention: 0Phobia (gamified self-guided VRET delivered through a smartphone app)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 180
Study: 27038050

Group type: EXPERIMENTAL
Intervention: Coping Long Term with Active Suicide Program (CLASP) - includes three individual in-person meetings, one significant other/family meeting, and 11 brief phone contacts (15-30 minutes each).
Number of subjects: 0
Study: 23722352

Group type: EXPERIMENTAL
Intervention: 1 g of 1% oestrone cream applied once daily for 24 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle cream applied once daily for 24 weeks
Number of subjects: 40
Study: 22704121

Group type: EXPERIMENTAL
Intervention: Pelvic plexus block (2.5 ml lidocaine 1% plus naropine 0.75%) plus intrarectal local anesthesia (lidocaine 1.5%-nifedipine 0.3% cream)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Periprostatic nerve block (2.5 ml of the same mixture) plus intrarectal local anesthesia (lidocaine 1.5%-nifedipine 0.3% cream)
Number of subjects: 180
Study: 20212376

Group type: EXPERIMENTAL
Intervention: Cutting balloon angioplasty (CBA)
Number of subjects: 19
Study: 17296646

Group type: EXPERIMENTAL
Intervention: Intensive treatment (n = 109)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Usual care (n = 100)
Number of subjects: 209
Study: 16145184

Group type: EXPERIMENTAL
Intervention: Dyspnea self-management program with 24 supervised exercise sessions
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dyspnea self-management program with 4 supervised exercise sessions
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dyspnea self-management program with no supervised exercise sessions
Number of subjects: 100
Study: 11442188

Group type: EXPERIMENTAL
Intervention: 0.5% timolol solution twice daily
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 0.5% timolol gel once daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 25
Study: 9776370

Group type: EXPERIMENTAL
Intervention: Psychotropic medications and counseling (index group)
Number of subjects: 81

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 81
Study: 8152764

Group type: EXPERIMENTAL
Intervention: Methazolamide
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Methazolamide (extended treatment)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 3395668

Group type: EXPERIMENTAL
Intervention: Controlled release pseudoephedrine suspension (CR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Immediate release reference syrup (IR-Sudafed)
Number of subjects: 16
Study: 31444706

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 28668671

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine 36 mg/day
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine 24 mg/day
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine 12 mg/day
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 25997442

Group type: EXPERIMENTAL
Intervention: Rotigotine-Rotigotine
Number of subjects: 346

Group type: COMPARATOR
Intervention: Placebo-Rotigotine
Number of subjects: 346
Study: 24721615

Group type: EXPERIMENTAL
Intervention: Earlier non-pneumatic anti-shock garment intervention
Number of subjects: 0
Study: 20851483

Group type: COMPARATOR
Intervention: Conventional advice (control group)
Number of subjects: 1957
Study: 19552702

Group type: EXPERIMENTAL
Intervention: 3-hour sleep group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-hour sleep group
Number of subjects: 0

Group type: COMPARATOR
Intervention: 8-hour sleep group
Number of subjects: 0
Study: 17684202

Group type: EXPERIMENTAL
Intervention: Conventional beef burger meal with French fries, ketchup, and carbonated lemon-flavored soda (meal 1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vegetarian burger with French fries, ketchup, and carbonated lemon-flavored soda (meal 2)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vegetarian burger with salad, fruit, yogurt, and orange juice (meal 3)
Number of subjects: 24
Study: 15446505

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) measurements in patients with ischemia
Number of subjects: 62

Group type: COMPARATOR
Intervention: Magnetocardiography (MCG) measurements in healthy controls
Number of subjects: 62
Study: 11154542

Group type: EXPERIMENTAL
Intervention: Interactive videodisc with a booklet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Booklet alone
Number of subjects: 100
Study: 9382207

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (lmw-heparin) at 1.5-5 IE/kg body weight per hour
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (lmw-heparin) at 8-15 IE/kg body weight per hour
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 8103145

Group type: EXPERIMENTAL
Intervention: Octreotide infusion (50 micrograms intravenous bolus plus 50 micrograms per h intravenous infusion for 48 h)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Emergency sclerotherapy with 3% sodium tetradecyl sulphate
Number of subjects: 100
Study: 3093305

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms, q.i.d. orally (n = 77)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Misoprostol 300 micrograms, q.i.d. orally (n = 76)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo (n = 76)
Number of subjects: 229
Study: 31919940

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) applied for 8 weeks
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 29504325

Group type: EXPERIMENTAL
Intervention: Biliary stenting
Number of subjects: 47

Group type: COMPARATOR
Intervention: Surgical bypass
Number of subjects: 47
Study: 27030533

Group type: EXPERIMENTAL
Intervention: DHA-rich fish-oil capsules (800 mg DHA/d)
Number of subjects: 1531

Group type: COMPARATOR
Intervention: Vegetable-oil capsules (control group)
Number of subjects: 1531
Study: 25519880

Group type: EXPERIMENTAL
Intervention: Preventive chemotherapy with praziquantel (exact dosage and duration not specified)
Number of subjects: 12110

Group type: EXPERIMENTAL
Intervention: Cost and coverage data for different intervention arms
Number of subjects: 12110

Group type: EXPERIMENTAL
Intervention: Environmental, political, and other characteristics impacting infection prevalence and intensity
Number of subjects: 12110
Study: 23289187

Group type: EXPERIMENTAL
Intervention: Epolyrec (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Eprex (n = 25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both Epolyrec and Eprex
Number of subjects: 50
Study: 19926918

Group type: EXPERIMENTAL
Intervention: Pitavastatin (2 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 30
Study: 18230353

Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg x 3/day, group A)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Glimepiride (2 mg/day, group G)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Diet only (group D)
Number of subjects: 37
Study: 15722313

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of 20-25 mg of triamcinolone acetonide
Number of subjects: 136

Group type: COMPARATOR
Intervention: Focal or panretinal laser treatment
Number of subjects: 136
Study: 14511391

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT), phenobarbital, or carbamazepine (CBZ)
Number of subjects: 890

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 890

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 890

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) or Carbamazepine (CBZ)
Number of subjects: 890
Study: 10498402

Group type: EXPERIMENTAL
Intervention: gly/gly genotype
Number of subjects: 832

Group type: COMPARATOR
Intervention: asp/asp genotype
Number of subjects: 832
Study: 8894058

Group type: EXPERIMENTAL
Intervention: TMD patients during stress condition
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TMD patients during nonstress periods
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control subjects during nonstress periods
Number of subjects: 40
Study: 8319361

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 3522466

Group type: EXPERIMENTAL
Intervention: Metronidazole alone
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Metronidazole and cefazolin
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Metronidazole and tobramycin
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 29512336

Group type: EXPERIMENTAL
Intervention: Temporary anchorage devices (TADs) used in orthodontic treatment, including 50 (3M ESPE), 56 (Bone screw), and 74 (Morelli) TADs, with lengths of 6, 8, and 10 mm and diameters of 1.5, 1.6, and 1.8 mm, and force levels set at 50, 100, 150, 200, and 250 g.
Number of subjects: 82
Study: 27734422

Group type: EXPERIMENTAL
Intervention: Retrograde intrarenal surgery (RIRS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy (SWL)
Number of subjects: 0
Study: 23949578

Group type: EXPERIMENTAL
Intervention: Albuterol administration (mean 12.3 mg prior to baseline)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Albuterol administration
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Hyperlactatemia
Number of subjects: 175
Study: 21104488

Group type: EXPERIMENTAL
Intervention: Self-hypnosis with VR imagery
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Standard self-hypnosis
Number of subjects: 35

Group type: COMPARATOR
Intervention: Relaxation interventions
Number of subjects: 35
Study: 19395177

Group type: EXPERIMENTAL
Intervention: SOCRATES questionnaire
Number of subjects: 337
Study: 17445348

Group type: EXPERIMENTAL
Intervention: Chicory inulin (CH)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Jerusalem artichoke inulin (JA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (snack bars without fructans)
Number of subjects: 45
Study: 15076203

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg without active pretreatment (placebo)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg after 5 days' treatment with amiloride 5 mg twice daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg after 5 days' treatment with chlorthalidone 50 mg once daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (no active drugs)
Number of subjects: 10
Study: 12536532

Group type: EXPERIMENTAL
Intervention: BZX treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Western medicine (control)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy control group (HCG)
Number of subjects: 42
Study: 9286940

Group type: EXPERIMENTAL
Intervention: Fradafiban (1 to 15 mg continuously infused over 30 minutes)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Lefradafiban (single oral doses of 50 mg, 100 mg, and 150 mg)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Lefradafiban (oral TID for 7 days)
Number of subjects: 130
Study: 7964712

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 25

Group type: COMPARATOR
Intervention: No drug period
Number of subjects: 25
Study: 3598611

Group type: EXPERIMENTAL
Intervention: Cimetidine, 300 mg orally four times daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Combination of N-phosphonacetyl-L-aspartate (PALA) plus L-alanosine
Number of subjects: 40
Study: 29359632

Group type: EXPERIMENTAL
Intervention: VIPP-V
Number of subjects: 77

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 77
Study: 28682929

Group type: EXPERIMENTAL
Intervention: Rasagiline (1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Safinamide (50 mg or 100 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (without monoamine oxidase B inhibitor intake)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Previous oral levodopa intakes
Number of subjects: 0
Study: 24967744

Group type: EXPERIMENTAL
Intervention: n-butyl cyanoacrylate (Glubran 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pelvic lymphadenectomy without n-butyl cyanoacrylate (control)
Number of subjects: 30
Study: 24309336

Group type: EXPERIMENTAL
Intervention: Propofol at a dose of 2 to 2.5 mg/kg as induction dose and sedation maintained with 5 to 10 mg/min.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 25
Study: 20451972

Group type: EXPERIMENTAL
Intervention: No scalpel vasectomy with distal vasal flushing (30 mL of sterile water)
Number of subjects: 727

Group type: COMPARATOR
Intervention: No scalpel vasectomy alone
Number of subjects: 727
Study: 19030713

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg, orally in a single dose, 1 hour before bedtime for 21 consecutive days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo, orally in a single dose, 1 hour before bedtime for 21 consecutive days
Number of subjects: 30
Study: 16847677

Group type: EXPERIMENTAL
Intervention: MS-trial (motion sickness induced)
Number of subjects: 11

Group type: COMPARATOR
Intervention: CN (control trial)
Number of subjects: 11
Study: 12514272

Group type: EXPERIMENTAL
Intervention: Choline supplementation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Carnitine supplementation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Choline plus Carnitine supplementation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Exercise regimen
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 10664112

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional resection
Number of subjects: 60
Study: 8657519

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg rhSOD
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 5 mg/kg rhSOD
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 1724525

Group type: EXPERIMENTAL
Intervention: Lovastatin and guar gum (L + GG 20 g/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Lovastatin and cholestyramine (L + C 16 g/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Comparison of L + C vs L + GG
Number of subjects: 62
Study: 6846123

Group type: EXPERIMENTAL
Intervention: 6-week rehabilitation program after MI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 0
Study: 30893349

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (US)
Number of subjects: 73

Group type: COMPARATOR
Intervention: No ultrasound guidance (NUS)
Number of subjects: 73
Study: 28437553

Group type: EXPERIMENTAL
Intervention: Experimental hybrids of C. baccatum var. pendulum
Number of subjects: 9
Study: 27187774

Group type: EXPERIMENTAL
Intervention: Single segment/low segments VTS
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: T4 VTS
Number of subjects: 1200

Group type: COMPARATOR
Intervention: T2/T3 VTS
Number of subjects: 1200
Study: 25146918

Group type: EXPERIMENTAL
Intervention: Self-gripping lightweight polyester mesh
Number of subjects: 557

Group type: COMPARATOR
Intervention: Sutured lightweight polypropylene mesh
Number of subjects: 557
Study: 22211678

Group type: EXPERIMENTAL
Intervention: Sucrose chewing gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xylitol chewing gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 20616707

Group type: EXPERIMENTAL
Intervention: Pridopidine (50 mg/d)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 17703632

Group type: EXPERIMENTAL
Intervention: Insulin glulisine (Apidra®)
Number of subjects: 0
Study: 16393213

Group type: EXPERIMENTAL
Intervention: Eradication treatment (group 1)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo (group 2)
Number of subjects: 145

Group type: COMPARATOR
Intervention: H. pylori-negative group (group 3)
Number of subjects: 145
Study: 12359037

Group type: EXPERIMENTAL
Intervention: Individual motivational interview (n=79)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Self-help booklet (control condition; n=81)
Number of subjects: 160
Study: 10459447

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of urinary follicle‐stimulating hormone (FSH, Fostimon 75, A.M.S.A., Italy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Subcutaneous administration of urinary follicle‐stimulating hormone (FSH, Metrodin 75 HP, Serono, Italy)
Number of subjects: 60
Study: 7818317

Group type: EXPERIMENTAL
Intervention: Deferoxamine (group D; n = 7)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (group C; n = 7)
Number of subjects: 14
Study: 2354093

Group type: EXPERIMENTAL
Intervention: Buccal morphine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 90216

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Captopril + Hydrochlorothiazide
Number of subjects: 17
Study: 31622150

Group type: EXPERIMENTAL
Intervention: Post-hurricane patients
Number of subjects: 597

Group type: COMPARATOR
Intervention: Pre-hurricane patients
Number of subjects: 597
Study: 28758717

Group type: EXPERIMENTAL
Intervention: EPA+DHA therapy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 25827800

Group type: EXPERIMENTAL
Intervention: Rabeprazole 10mg for 4 weeks
Number of subjects: 83
Study: 23288871

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 124
Study: 22084332

Group type: EXPERIMENTAL
Intervention: Dabigatran, 150 mg twice daily
Number of subjects: 18112

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18112

Group type: EXPERIMENTAL
Intervention: Dabigatran, 150 mg or 110 mg twice daily
Number of subjects: 18112
Study: 19370286

Group type: EXPERIMENTAL
Intervention: Self-care education
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no self-care education)
Number of subjects: 80
Study: 16877072

Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate 0.15% preserved with polyquaternium-1 (brimonidine PQ)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Brimonidine tartrate 0.15% preserved with chlorine dioxide (brimonidine P)
Number of subjects: 842